Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Show more
- Additional Phase 2 TORREY Open-Label Extension Data to be Presented in Vienna - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and...
- $354 Million in Cash, Cash Equivalents & Marketable Securities, as of June 30, 2024 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.055 | 5.82010582011 | 0.945 | 1.07 | 0.871 | 1020370 | 0.98081929 | CS |
4 | 0.106 | 11.8568232662 | 0.894 | 1.07 | 0.8217 | 897904 | 0.92607936 | CS |
12 | 0.0913 | 10.0473203477 | 0.9087 | 1.37 | 0.7666 | 1182314 | 1.00782338 | CS |
26 | -0.33 | -24.8120300752 | 1.33 | 1.37 | 0.4993 | 1772407 | 0.8502552 | CS |
52 | 0.208 | 26.2626262626 | 0.792 | 1.6 | 0.4525 | 1678548 | 0.86220593 | CS |
156 | -11.15 | -91.7695473251 | 12.15 | 15.195 | 0.4525 | 1967476 | 3.26466267 | CS |
260 | -20.91 | -95.4358740301 | 21.91 | 27.1497 | 0.4525 | 1415782 | 4.75545262 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.